Your email has been successfully added to our mailing list.

×
0 -0.00284552845528456 -0.00650406504065041 -0.0067073170731707 -0.00650406504065041 -0.0106300813008131 -0.0195121951219512 -0.0067073170731707
Stock impact report

Here's Why Ionis Pharmaceuticals and Akcea Therapeutics Plummeted Today [The Motley Fool]

AKCEA THERAPEUTICS (AKCA) 
Last akcea therapeutics earnings: 2/25 04:05 pm Check Earnings Report
Company Research Source: The Motley Fool
The FDA gives a thumbs down to their triglyceride-lowering drug Waylivra. Brian Orelli ( TMFBiologyFool ) Aug 28, 2018 at 12:51PM What happened Shares of Akcea Therapeutics ( NASDAQ:AKCA ) are down 26% at 11:41 a.m. EDT while Ionis Pharmaceuticals ( NASDAQ:IONS ) is down 16% after the FDA issued a complete response letter -- the agency's euphemism for a rejection -- for their triglyceride-lowering drug Waylivra that was up for approval for a rare genetic disease called familial chylomicronemia syndrome (FCS). So what Image source: Getty Images. Akcea Therapeutics and Ionis Pharmaceuticals squeaked though the FDA's Metabolism and Endocrinology Products Advisory Committee with a 12-8 recommendation to approve the drug, with a majority of the outside experts voting that the efficacy justified the risk of thrombocytopenia, or low blood Show less Read more
Impact Snapshot
Event Time:
AKCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AKCA alerts
Opt-in for
AKCA alerts

from News Quantified
Opt-in for
AKCA alerts

from News Quantified